Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 26.58
+0.63 (2.43%)
Feb 3, 2026, 3:00 PM CST
Guobang Pharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 872.95 | 781.6 | 612.46 | 920.9 | 706.03 | 810 |
Depreciation & Amortization | 432.83 | 432.83 | 321.14 | 260.29 | 201.12 | 157.11 |
Other Amortization | 1.13 | 1.13 | 1.24 | 1.5 | 1.18 | 0.75 |
Loss (Gain) From Sale of Assets | 9.11 | 9.11 | - | 0.05 | -0.3 | 1.52 |
Asset Writedown & Restructuring Costs | 6.54 | 6.54 | 5.08 | 15.84 | 61.14 | 19.71 |
Loss (Gain) From Sale of Investments | -27.35 | -27.35 | -23.56 | -24.09 | -10.53 | -3.27 |
Provision & Write-off of Bad Debts | 12.07 | 12.07 | -7.17 | 11.72 | 0.92 | -0.54 |
Other Operating Activities | 306.46 | 25.19 | 43.28 | 9.44 | 33.35 | 68.39 |
Change in Accounts Receivable | -634.31 | -634.31 | -929.35 | -255.53 | -841.81 | -51.43 |
Change in Inventory | -20.68 | -20.68 | 9.2 | -127.53 | -371.61 | -157.22 |
Change in Accounts Payable | 120.73 | 120.73 | 488.71 | 179.69 | 48.23 | -75.53 |
Change in Other Net Operating Assets | 4.87 | 4.87 | -2.47 | 4.56 | 1.62 | -1.04 |
Operating Cash Flow | 1,079 | 706.41 | 516.76 | 1,017 | -176.18 | 767.7 |
Operating Cash Flow Growth | 100.29% | 36.70% | -49.19% | - | - | 74.14% |
Capital Expenditures | -481.97 | -419.12 | -748.44 | -803.12 | -448.04 | -521.43 |
Sale of Property, Plant & Equipment | 35.35 | 17.96 | 24.9 | 17.81 | 4.34 | 1.73 |
Investment in Securities | -189.88 | -112.68 | 362.07 | 373.54 | -1,252 | 154.47 |
Other Investing Activities | 11.5 | - | - | 0 | 5.65 | - |
Investing Cash Flow | -625 | -513.85 | -361.47 | -411.76 | -1,690 | -365.23 |
Short-Term Debt Issued | - | - | 1 | 1 | - | 2.5 |
Long-Term Debt Issued | - | 593.21 | 964 | 778.11 | 364.43 | 552.15 |
Total Debt Issued | 832.81 | 593.21 | 965 | 779.11 | 364.43 | 554.65 |
Short-Term Debt Repaid | - | - | -1 | -1 | - | -2.5 |
Long-Term Debt Repaid | - | -782.29 | -656.5 | -283 | -1,115 | -615.94 |
Total Debt Repaid | -877.85 | -782.29 | -657.5 | -284 | -1,115 | -618.44 |
Net Debt Issued (Repaid) | -45.05 | -189.08 | 307.5 | 495.11 | -750.3 | -63.79 |
Issuance of Common Stock | 97.11 | 97.11 | - | - | 2,677 | - |
Repurchase of Common Stock | -101.01 | -101.01 | - | - | - | - |
Common Dividends Paid | -355.88 | -194.1 | -361.64 | -128.21 | -333.74 | -188.04 |
Other Financing Activities | -105.76 | 0.58 | 8.2 | 0.05 | -22.18 | -22.03 |
Financing Cash Flow | -510.58 | -386.49 | -45.94 | 366.95 | 1,571 | -273.86 |
Foreign Exchange Rate Adjustments | 16.18 | 27.08 | 10.71 | 35.27 | -9.93 | -32.61 |
Net Cash Flow | -40.36 | -166.85 | 120.07 | 1,007 | -305.43 | 96 |
Free Cash Flow | 597.08 | 287.29 | -231.68 | 213.92 | -624.23 | 246.27 |
Free Cash Flow Margin | 10.05% | 4.88% | -4.33% | 3.74% | -13.86% | 5.85% |
Free Cash Flow Per Share | 1.07 | 0.52 | -0.42 | 0.38 | -1.22 | 0.52 |
Cash Income Tax Paid | 98.68 | 48.15 | -100.85 | 31.61 | 36.92 | 35.2 |
Levered Free Cash Flow | -90.77 | 48.92 | 134.75 | 340.79 | -852.93 | 258.2 |
Unlevered Free Cash Flow | -76.59 | 65.97 | 148.86 | 351.13 | -834.98 | 280.4 |
Change in Working Capital | -534.69 | -534.69 | -435.71 | -178.6 | -1,169 | -285.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.